Citations

Citations to this article as recorded by  

• Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  The Korean Journal of Internal Medicine.2017; 32(6): 967.     CrossRef
• Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  Diabetes & Metabolism Journal.2017; 41(5): 367.     CrossRef
• An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial
  Gyuri Kim, Ji Cheol Bae, Byoung Kee Yi, Kyu Yeon Hur, Dong Kyung Chang, Moon-Kyu Lee, Jae Hyeon Kim, Sang-Man Jin
  BMC Medical Informatics and Decision Making.2017;[Epub]     CrossRef
• Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
  Gyuri Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Yonsei Medical Journal.2016; 57(6): 1395.     CrossRef
• Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
  Jae-Seung Yun, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2015; 30(1): 6.     CrossRef
• Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes
  Sun Ok Song, You-Cheol Hwang, Kyu-Jeung Ahn, Bong Soo Cha, Young Duk Song, Dae Wook Lee, Byung-Wan Lee
  Diabetes Therapy.2015; 6(4): 547.     CrossRef
• The optimal morning:evening ratio in total dose of twice‐daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24‐week multi‐centre prospective, randomized controlled, open‐labelled clinical study
  C. H. Jung, J.‐Y. Park, J. H. Cho, K.‐H. Yoon, H. K. Yang, Y.‐H. Lee, B. S. Cha, B.‐W. Lee
  Diabetic Medicine.2014; 31(1): 68.     CrossRef
• The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub‐analysis from the A 1 chieve ® study
  Y.‐C. Hwang, J. G. Kang, K. J. Ahn, B. S. Cha, S.‐H. Ihm, S. Lee, M. Kim, B.‐W. Lee
  International Journal of Clinical Practice.2014; 68(11): 1338.     CrossRef
• Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)
  Byung-Wan Lee
  Diabetes & Metabolism Journal.2013; 37(3): 212.     CrossRef

Citations

Citations to this article as recorded by  

• Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia
  Lunbo Tan, Zijun Ouyang, Zhilong Chen, Fen Sun, Haichun Guo, Feng Wang, Monique Mulder, Yuan Sun, Xifeng Lu, Jian V. Zhang, A. H. Jan Danser, Koen Verdonk, Xiujun Fan, Qing Yang
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Chemerin Levels in Acute Coronary Syndrome: Systematic Review and Meta-Analysis
  Abdulrahman Ismaiel, Mohammad Zeeshan Ashfaq, Daniel-Corneliu Leucuta, Mohamed Ismaiel, Dilara Ensar Ismaiel, Stefan-Lucian Popa, Dan L Dumitrascu
  Laboratory Medicine.2022; 53(6): 552.     CrossRef
• Prognostic value of plasma adipokine chemerin in patients with coronary artery disease
  Bo Wang, Wenxin Kou, Shuya Ji, Rongrong Shen, Hongwei Ji, Jianhui Zhuang, Yifan Zhao, Bo Li, Wenhui Peng, Xuejing Yu, Hailing Li, Yawei Xu
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Role of Chemerin in Cardiovascular Diseases
  Mirjana T. Macvanin, Manfredi Rizzo, Jelena Radovanovic, Alper Sonmez, Francesco Paneni, Esma R. Isenovic
  Biomedicines.2022; 10(11): 2970.     CrossRef
• Chemerin in inflammatory diseases
  Xin Su, Ye Cheng, Guoming Zhang, Bin Wang
  Clinica Chimica Acta.2021; 517: 41.     CrossRef
• Chemerin activity in selected pathological states of human body – A systematic review
  Magdalena Acewicz, Irena Kasacka
  Advances in Medical Sciences.2021; 66(2): 270.     CrossRef
• Chemerin in atherosclerosis
  Jia-Xiang Sun, Chi Zhang, Zhe-Bin Cheng, Mu-Yao Tang, Yi-Zhang Liu, Jie-Feng Jiang, Xuan Xiao, Liang Huang
  Clinica Chimica Acta.2021; 520: 8.     CrossRef
• Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
  Anna Szpakowicz, Malgorzata Szpakowicz, Magda Lapinska, Marlena Paniczko, Slawomir Lawicki, Andrzej Raczkowski, Marcin Kondraciuk, Emilia Sawicka, Malgorzata Chlabicz, Marcin Kozuch, Maciej Poludniewski, Slawomir Dobrzycki, Irina Kowalska, Karol Kaminski
  Biomolecules.2021; 11(8): 1149.     CrossRef
• Novo Efeito Cardioprotetor da L-Carnitina em Camundongos Obesos Diabéticos: Regulação da Expressão de Quemerina e CMKLRI no Coração e Tecidos Adiposos
  Rezvan Amiri, Mohammad Reza Tabandeh, Seyed Ahmad Hosseini
  Arquivos Brasileiros de Cardiologia.2021; 117(4): 715.     CrossRef
• The role of adipokines in the regulation of cardiovascular function
  A. V. Karpushev, V. B. Mikhailova
  "Arterial’naya Gipertenziya" ("Arterial Hypertension").2020; 25(5): 448.     CrossRef
• The associations among RARRES2 rs17173608 gene polymorphism, serum chemerin, and non-traditional lipid profile in patients with metabolic syndrome
  Marwa A. Dahpy, Marwa K. Khairallah, Nashwa Mostafa A. Azoz, Ghada M. Ezzat
  Egyptian Journal of Medical Human Genetics.2020;[Epub]     CrossRef
• Serum chemerin as a predictor of left ventricle hypertrophy in patients with coronary artery disease
  NohaHasssanin Hanboly, Yasser Sharaf, Mervat Al-Anany, Essam Saeed
  Nigerian Journal of Cardiology.2019; 16(1): 25.     CrossRef
• Association of Circulating Chemerin With Subclinical Parameters of Atherosclerosis
  Stephanie Zylla, Marcus Dörr, Henry Völzke, Ulf Schminke, Stephan B. Felix, Matthias Nauck, Nele Friedrich
  Arteriosclerosis, Thrombosis, and Vascular Biology.2018; 38(7): 1656.     CrossRef
• Six weeks of combined aerobic and resistance exercise using outdoor exercise machines improves fitness, insulin resistance, and chemerin in the Korean elderly: A pilot randomized controlled trial
  Dong-Il Kim, Dong Hoon Lee, Sunghyun Hong, Sung-won Jo, Young-shin Won, Justin Y. Jeon
  Archives of Gerontology and Geriatrics.2018; 75: 59.     CrossRef
• Relationship between serum chemerin levels and insulin resistance index and cardio–respiratory function in non–active obese and lean men
  Mehdi Abbaszadegan, Farhad Kouhi achachluie
  Advances in Obesity, Weight Management & Control.2018;[Epub]     CrossRef
• Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis
  Tarek M.K. Motawi, Soliman G. Mahdy, Maha M. El-Sawalhi, Eman N. Ali, Rania Farag A. El-Telbany
  Canadian Journal of Physiology and Pharmacology.2018; 96(1): 38.     CrossRef
• Plasma CXCL1 levels and TRAF3IP2 variants in patients with myocardial infarction
  Safoora Pordel, Mahdi Sajedi Khanian, Mohammad Hossein Karimi, Hossein Nikoo, Mehrnoosh Doroudchi
  Journal of Clinical Laboratory Analysis.2018;[Epub]     CrossRef
• Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects
  Dae Young Cheon, Jun Goo Kang, Seong Jin Lee, Sung Hee Ihm, Eun Jig Lee, Moon Gi Choi, Hyung Joon Yoo, Chul Sik Kim
  Yonsei Medical Journal.2017; 58(2): 319.     CrossRef
• The comparison of chemerin, adiponectin and lipid profile indices in obese and non-obese adolescents
  Zahra Maghsoudi, Roya Kelishadi, Mohammad Javad Hosseinzadeh-Attar
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2016; 10(2): S43.     CrossRef
• Chemerin processing in the myocardium: A mechanism in search of a function
  Michael V.G. Latronico, Gianluigi Condorelli
  Journal of Molecular and Cellular Cardiology.2016; 100: 21.     CrossRef
• Chemerin as an independent predictor of cardiovascular event risk
  Sinan İnci, Gökhan Aksan, Pınar Doğan
  Therapeutic Advances in Endocrinology and Metabolism.2016; 7(2): 57.     CrossRef
• Chemerin level in pregnancies complicated by preeclampsia and its relation with disease severity and neonatal outcomes
  Orkun Cetin, Zehra Kurdoglu, Mertihan Kurdoglu, H. Guler Sahin
  Journal of Obstetrics and Gynaecology.2016; : 1.     CrossRef
• Chemerin in renal dysfunction and cardiovascular disease
  Mario Bonomini, Assunta Pandolfi
  Vascular Pharmacology.2016; 77: 28.     CrossRef
• High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events — Insights from phenotype and genotype characterization
  Andreas Leiherer, Axel Muendlein, Elena Kinz, Alexander Vonbank, Philipp Rein, Peter Fraunberger, Cornelia Malin, Christoph H. Saely, Heinz Drexel
  Vascular Pharmacology.2016; 77: 60.     CrossRef
• Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia
  Liqiong Wang, Tianli Yang, Yiling Ding, Yan Zhong, Ling Yu, Mei Peng
  Endocrine.2015; 48(1): 299.     CrossRef
• Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation
  Erkan Özcan, N. Işıl Saygun, Muhittin A. Serdar, Nezahat Kurt
  Clinical Oral Investigations.2015; 19(4): 921.     CrossRef
• Elevated serum chemerin in Chinese women with hyperandrogenic PCOS
  LiQiong Wang, Yan Zhong, YiLing Ding, XiaoBo Shi, Jian Huang, FuFan Zhu
  Gynecological Endocrinology.2014; 30(10): 746.     CrossRef
• Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?
  Karla Bianca Neves, Núbia S. Lobato, Rhéure Alves Moreira Lopes, Fernando P. Filgueira, Camila Ziliotto Zanotto, Ana Maria Oliveira, Rita C. Tostes
  Clinical Science.2014; 127(2): 111.     CrossRef
• Chemerin levels as predictor of acute coronary events: A case–control study nested within the veterans affairs normative aging study
  Konstantinos N. Aronis, Ayse Sahin-Efe, John P. Chamberland, Avron Spiro, Pantel Vokonas, Christos S. Mantzoros
  Metabolism.2014; 63(6): 760.     CrossRef
• The predictive value of the first-trimester maternal serum chemerin level for pre-eclampsia
  Qiu-Lian Xu, Min Zhu, Yan Jin, Nan Wang, Hai-Xia Xu, Li-Mei Quan, Shan-Shan Wang, Shan-Shan Li
  Peptides.2014; 62: 150.     CrossRef
• Evaluation of Circulating Adipokines and Abdominal Obesity as Predictors of Significant Myocardial Ischemia Using Gated Single-Photon Emission Computed Tomography
  Chi-Sheng Hung, Yen-Wen Wu, Jei-Yie Huang, Pei-Ying Hsu, Ming-Fong Chen, Xin-Liang Ma
  PLoS ONE.2014; 9(5): e97710.     CrossRef
• Towards an integrative approach to understanding the role of chemerin in human health and disease
  J. L. Rourke, H. J. Dranse, C. J. Sinal
  Obesity Reviews.2013; 14(3): 245.     CrossRef
• The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults
  Mi Kyung Lee, Sang Hui Chu, Duk Chul Lee, Ki Yong An, Ji-Hye Park, Dong Il Kim, Jiyoung Kim, Sunghyun Hong, Jee Aee Im, Ji Won Lee, Justin Y. Jeon
  Clinica Chimica Acta.2013; 421: 109.     CrossRef
• Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes
  Syeda Sadia Fatima, Kiymet Bozaoglu, Rehana Rehman, Faiza Alam, Abdul Shakoor Memon, Pascale Chavatte-Palmer
  PLoS ONE.2013; 8(2): e57113.     CrossRef
• Chemerin: a potential endocrine link between obesity and type 2 diabetes
  Alexandra A. Roman, Sebastian D. Parlee, Christopher J. Sinal
  Endocrine.2012; 42(2): 243.     CrossRef
• Elastase and Tryptase Govern TNFα-Mediated Production of Active Chemerin by Adipocytes
  Sebastian D. Parlee, Jenna O. McNeil, Shanmugam Muruganandan, Christopher J. Sinal, Kerry B. Goralski, Charaf Benarafa
  PLoS ONE.2012; 7(12): e51072.     CrossRef
• Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
  Hyun Min Kim, Byung-Wan Lee, Young-Mi Song, Won Jin Kim, Hyuk-Jae Chang, Dong-Hoon Choi, Hee Tae Yu, EunSeok Kang, Bong Soo Cha, Hyun Chul Lee
  Cardiovascular Diabetology.2012;[Epub]     CrossRef
• The association of serum chemerin level with risk of coronary artery disease in Chinese adults
  Qun Yan, Yifei Zhang, Jie Hong, Weiqiong Gu, Meng Dai, Juan Shi, Ying Zhai, Weiqing Wang, Xiaoying Li, Guang Ning
  Endocrine.2012; 41(2): 281.     CrossRef
• Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
  Jung Hee Kim, Dae Jung Kim, Hak Chul Jang, Sung Hee Choi
  Diabetes & Metabolism Journal.2011; 35(6): 571.     CrossRef
• Chemerin: A Novel Link between Inflammation and Atherosclerosis?
  Eun-Jung Rhee
  Diabetes & Metabolism Journal.2011; 35(3): 216.     CrossRef